151 related articles for article (PubMed ID: 37089961)
1. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.
Ren R; Gao L; Li G; Wang S; Zhao Y; Wang H; Liu J
Front Pharmacol; 2023; 14():1177282. PubMed ID: 37089961
[No Abstract] [Full Text] [Related]
2. 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma.
Lian Z; Sang C; Li N; Zhai H; Bai W
Front Pharmacol; 2023; 14():1124895. PubMed ID: 36895941
[No Abstract] [Full Text] [Related]
3. Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma.
Pan M; Cheng L; Wang Y; Lyu C; Hou C; Zhang Q
Front Pharmacol; 2023; 14():1249041. PubMed ID: 37719847
[No Abstract] [Full Text] [Related]
4. 3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.
Zhuo W; Lian Z; Bai W; Chen Y; Xia H
Front Mol Biosci; 2023; 10():1164349. PubMed ID: 37065446
[No Abstract] [Full Text] [Related]
5. QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.
Lian Z; Tai Y; Xia H; Zhai H
Anticancer Agents Med Chem; 2023; 23(6):726-733. PubMed ID: 36017845
[TBL] [Abstract][Full Text] [Related]
6. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.
Wang M; Qiu B; Wang W; Li X; Huo H
Anticancer Agents Med Chem; 2023; 23(19):2146-2153. PubMed ID: 37653634
[TBL] [Abstract][Full Text] [Related]
7. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
8. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
[TBL] [Abstract][Full Text] [Related]
9. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
Tong L; Guo L; Lv X; Li Y
J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
[TBL] [Abstract][Full Text] [Related]
10. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
12.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Assefa H; Kamath S; Buolamwini JK
J Comput Aided Mol Des; 2003 Aug; 17(8):475-93. PubMed ID: 14703120
[TBL] [Abstract][Full Text] [Related]
14. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
[TBL] [Abstract][Full Text] [Related]
15. 3D-chiral atom, atom-type, and total non-stochastic and stochastic molecular linear indices and their applications to central chirality codification.
Marrero-Ponce Y; Castillo-Garit JA
J Comput Aided Mol Des; 2005 Jun; 19(6):369-83. PubMed ID: 16231198
[TBL] [Abstract][Full Text] [Related]
16. Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.
Tong JB; Luo D; Feng Y; Bian S; Zhang X; Wang TH
Mol Divers; 2021 Aug; 25(3):1855-1872. PubMed ID: 33392965
[TBL] [Abstract][Full Text] [Related]
17. Examining the predictive accuracy of the novel 3D N-linear algebraic molecular codifications on benchmark datasets.
García-Jacas CR; Contreras-Torres E; Marrero-Ponce Y; Pupo-Meriño M; Barigye SJ; Cabrera-Leyva L
J Cheminform; 2016; 8():10. PubMed ID: 26925168
[TBL] [Abstract][Full Text] [Related]
18. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Balupuri A; Balasubramanian PK; Cho SJ
Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
[TBL] [Abstract][Full Text] [Related]
19. QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease.
Song F; Sun H; Ma X; Wang W; Luan M; Zhai H; Su G; Liu Y
Front Pharmacol; 2023; 14():1185004. PubMed ID: 37266150
[No Abstract] [Full Text] [Related]
20. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]